Researchers have turned a CRISPR enzyme into an antiviral that can be programmed to detect and destroy RNA-based viruses in human cells.

A new survey by Harvard researchers shows that trust in leaders and institutions are at a low ebb in the eastern Democratic Republic of the Congo, highlighting the importance of gaining trust as part of the response to the growing Ebola epidemic there.